| Authors: |
Hatton CF; The Pirbright Institute, Pirbright, UK., Briggs E; The Pirbright Institute, Pirbright, UK.; The University of Surrey, Guildford, UK., Polychronakis E; The Pirbright Institute, Pirbright, UK., Vats A; The Pirbright Institute, Pirbright, UK., Sharma B; The Pirbright Institute, Pirbright, UK., Wongborphid S; The Pirbright Institute, Pirbright, UK., Cayol T; The Pirbright Institute, Pirbright, UK., Sedaghat-Rostami E; The Pirbright Institute, Pirbright, UK.; The University of Surrey, Guildford, UK., Manoharan S; The Pirbright Institute, Pirbright, UK., Guan A; The Pirbright Institute, Pirbright, UK.; The University of Manchester, Manchester, United Kingdom., Moorhouse EJ; The Pirbright Institute, Pirbright, UK., MacLoughlin R; Aerogen Ltd, Galway, Ireland., Rijal P; Chinese Academy of Medical Science Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Townsend AR; Chinese Academy of Medical Science Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Salguero FJ; United Kingdom Health Security Agency, UKHSA-Porton Down, Salisbury, UK., Pauydal B; The Pirbright Institute, Pirbright, UK., Tchilian E; The Pirbright Institute, Pirbright, UK. elma.tchilian@pirbright.ac.uk.; The University of Surrey, Guildford, UK. elma.tchilian@pirbright.ac.uk. |
